Ctrl

K

Pralidoxime

Intravenous
Subcutaneous
Intramuscular
Class
Antidotes
Subclass
Acetylcholinesterase reactivators
Generic name
Pralidoxime
Common formulations
Powder for parenteral solution
Dosage and administration
Adults patients
Treatment of organophosphate poisoning
1,000-2,000 mg IV q12h
Indications for use
Labeled indications
Adults
Treatment of organophosphate poisoning
Children
Treatment of excessive perspiration
Pregnancy and breastfeeding
Pregnancy
All trimesters
Use only if benefits outweigh potential risks.
Breastfeeding
Little information available on breastfeeding safety.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Interactions
Drug(s)
Check Interactions
Reset

What did you think about this content?

Create free account

Sign up for free to access the full drug resource